QTTB — Q32 Bio Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1661998 ·
Last close
$8.63
Market Cap
$258.24M
52W High
$23.57
52W Low
$1.90
ADV30
477,137
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 0 | — | -10,660,000 | -8,922,000 | 297,201,000 | 289,587,000 | 9,531,000 |
| Jun 2026 | 0 | — | -9,118,000 | -8,946,000 | 115,867,000 | 106,270,000 | 9,962,000 |
| Mar 2026 | 0 | — | -7,722,000 | -7,609,000 | 63,675,000 | 50,751,000 | 17,362,000 |
| Dec 2025 | 53,737,000 | — | 45,879,000 | 57,730,000 | 61,776,000 | 48,297,000 | 19,762,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-20,016,000
Investing CF
$7,000,000
Financing CF
$253,616,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.84
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-230,470,000
Inventory
—
Receivables
$555,000
ST Investments
—
EBIT TTM
$30,430,000
Pretax Income TTM
$32,253,000
Interest Exp TTM
$1,100,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$53,737,000
EBITDA
$18,728,000
Free Cash Flow
$14,419,875
Enterprise Value
$-8,427,092
Total Cash
$289,587,008
Total Debt
$4,364,000
Shares Out
29,923,882
Trailing EPS
$3.60
Book Value
$9.62
ROE
24.0%
ROA
6.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 53,737,000 | 16,902,000 | 29,821,000 | 61,776,000 | 19,762,000 | 42,014,000 | -33,543,000 |
| Dec 2024 | 0 | -66,102,000 | -47,733,000 | 92,332,000 | 86,657,000 | 5,675,000 | -67,715,000 |
| Dec 2023 | -6,651,000 | -48,255,000 | -53,743,000 | 47,057,000 | 229,978,000 | -182,921,000 | -18,677,000 |
| Dec 2022 | 6,651,000 | -39,225,000 | -42,809,000 | 61,774,000 | 192,486,000 | -130,712,000 | -10,957,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$53,737,000
NetIncome TTM
$33,786,000
OpCashFlow TTM
—
Assets (Latest)
$115,867,000
Forward EPS
$-1.02
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $15.00 · spot: $8.53 · call volume: 27 · put volume: 234Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TTRX | Turn Therapeutics Inc. | $261.40M | $8.55 | — |
| ENTA | ENANTA PHARMACEUTICALS INC | $253.10M | $8.69 | — |
| CAMP | Camp4 Therapeutics Corp | $251.02M | $4.00 | — |
| NWBO | NORTHWEST BIOTHERAPEUTICS INC | $250.73M | $0.15 | — |
| PRE | Prenetics Global Ltd | $248.19M | $16.33 | — |
News headlines (Yahoo Finance, 1h cache)
Q32 Bio to Participate in the 2026 Jefferies Global Healthcare Conference in London
2026-11-11 11:59 · Yahoo
Q32 Bio: Q3 Earnings Snapshot
2026-11-04 12:11 · Yahoo
Q32 Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update
2026-11-04 11:59 · Yahoo
Q32 Bio Presents Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata in a Late-Breaker at the European Academy of Dermatology and Venereology Congress 2026
2026-09-30 13:15 · Yahoo
Q32 Bio Announces Upcoming Late-Breaking Presentation of Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata at the European Academy of Dermatology and Venereology Co
2026-09-21 13:15 · Yahoo
Q32 Bio Appoints José Trevejo, M.D., Ph.D., as Chief Medical Officer and Ellie Hershberger, Pharm.D., as Chief Development Officer
2026-09-14 10:59 · Yahoo
Down 23.1% in 4 Weeks, Here's Why Q32 Bio (QTTB) Looks Ripe for a Turnaround
2026-09-07 13:35 · Yahoo
Q32 Bio to Participate in Upcoming September Investor Conferences
2026-09-01 10:59 · Yahoo
Wall Street Analysts See an 182.18% Upside in Q32 Bio (QTTB): Can the Stock Really Move This High?
2026-08-17 13:55 · Yahoo
Are You Looking for a Top Momentum Pick? Why Q32 Bio (QTTB) is a Great Choice
2026-07-20 16:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.